A simpler diagnostic formula for screening nonalcoholic fatty liver disease

Area of Science:

• Hepatology and Gastroenterology
• Medical Diagnostics
• Biostatistics

Background:

• Nonalcoholic fatty liver disease (NAFLD) is a growing global health concern.
• Accurate non-invasive diagnostic methods for NAFLD are crucial for timely intervention.
• Current diagnostic tools have limitations in sensitivity and specificity.

Purpose of the Study:

• To develop and validate a novel diagnostic formula for NAFLD.
• To integrate clinical and laboratory indicators for improved diagnostic accuracy.
• To compare the efficacy of the new formula against existing methods like FibroScan.

Main Methods:

• A cohort of 141 NAFLD patients and 30 healthy controls was studied.
• Data collected included clinical history, BMI, liver enzymes (ALT, AST), uric acid (UA), and FibroScan results.
• Statistical analyses involved linear correlation, multiple linear regressions, and ROC curve analysis.

Main Results:

• Key diagnostic indices identified were BMI, ALT, AST, and UA.
• A regression formula (CAP = 113.163 + 0.252*ALT + 6.316*BMI) was developed.
• The formula achieved 92.7% area under the ROC curve, with 87.68% sensitivity and 90% specificity, outperforming FibroScan (82.6% vs 69.6% accuracy).

Conclusions:

• The proposed formula offers a highly sensitive and specific non-invasive method for NAFLD diagnosis.
• Its accuracy significantly surpasses that of FibroScan.
• The formula's simplicity and reliance on readily available data facilitate convenient clinical application.